BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 3,480.00
-155.00 (-4.26%)
Jun 10, 2026, 3:30 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 19.83B KRW in the quarter ending March 31, 2026, with 25.36% growth. This brings the company's revenue in the last twelve months to 79.81B, up 7.37% year-over-year. In the year 2025, BCWORLD PHARM. had annual revenue of 75.80B with 1.32% growth.
Revenue (ttm)
79.81B
Revenue Growth
+7.37%
P/S Ratio
0.46
Revenue / Employee
285.04M
Employees
280
Market Cap
36.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.80B | 985.64M | 1.32% |
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.81T |
| Celltrion | 4.47T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 203.76B |
| MYUNGMOON Pharm co.,Ltd | 197.37B |
| Aprogen Biologics | 78.00B |
| Tdspharm | 30.41B |
| HASS Corp. | 16.58B |